Sun Pharma faces risk from Trump's latest tariffs, overall impact on Indian firms minimal

The US will impose a 100% tariff on branded and patented drugs from October 1. Generic drugs remain exempt, reducing overall effects on other Indian companies.

from Business News: Get Latest Business News Today along with Share Market updates and Indian Stock Market News | Hindustan Times https://ift.tt/4epJKdM